Elanco Animal Health Incorporated Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Elanco Animal Health Incorporated (ELAN) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $6.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2023-05-09
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2023-03-31 was $6.00M, a 45.45% decline year-over-year.
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-09-30 was $1.00M.
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-06-30 was $4.00M.
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-03-31 was $11.00M, a 38.89% decline year-over-year.
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $17.00M, a 15.00% decline from fiscal 2021.
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for fiscal 2021 was $20.00M, a 33.33% increase from fiscal 2020.
- Elanco Animal Health Incorporated share-based payment arrangement, decrease for tax withholding obligation for fiscal 2020 was $15.00M.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month as first filed | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-03-31 | $6.00M 10-Q · filed 2023-05-09 | |||||
| 2022-12-31 | $17.00M 10-K · filed 2023-03-01 | |||||
| 2022-09-30 | $1.00M 10-Q · filed 2022-11-08 | $5.00M derived: sum of 2 quarters · filed 2022-11-08 | $16.00M derived: sum of 3 quarters · filed 2023-05-09 | |||
| 2022-06-30 | $4.00M 10-Q · filed 2022-11-08 | $15.00M derived: sum of 2 quarters · filed 2023-05-09 | ||||
| 2022-03-31 | $11.00M 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | $20.00M 10-K · filed 2023-03-01 | |||||
| 2021-03-31 | $18.00M 10-Q · filed 2022-11-08 | |||||
| 2020-12-31 | $15.00M 10-K · filed 2023-03-01 | $14.40M 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | $200.00K 10-Q · filed 2020-11-06 | $1.00M derived: sum of 2 quarters · filed 2021-11-05 | $14.00M derived: sum of 3 quarters · filed 2021-11-05 | ||
| 2020-06-30 | $1.00M 10-Q · filed 2021-11-05 | $14.00M derived: sum of 2 quarters · filed 2021-11-05 | ||||
| 2020-03-31 | $13.00M 10-Q · filed 2021-11-05 | $12.80M 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |